Self-treatment and self-medication of Swiss primary care physicians: a cause for concern?

Most read articles by the same author(s)

• Dominik Glinz, Viktoria L. Gloy, Andreas U. Monsch, Reto W. Kressig, Chandni Patel, Kimberly Alba McCord, Zanfina Ademi, Yuki Tomonaga, Matthias Schwenkglenks, Heiner C. Bucher, Heike Raatz, Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis , Swiss Medical Weekly: Vol. 149 No. 2526 (2019)
• David Conen, Nicolas Rodondi, Andreas Müller, Juerg H. Beer, Angelo Auricchio, Peter Ammann, Daniel Hayoz, Richard Kobza, Giorgio Moschovitis, Dipen Shah, Jürg Schläpfer, Jan Novak, Marcello Di Valentino, Paul Erne, Christian Sticherling, Leo H. Bonati, Georg Ehret, Laurent Roten, Urs Fischer, Andreas Monsch, Christoph Stippich, Jens Wuerfel, Matthias Schwenkglenks, Michael Kühne, Stefan Osswald, for the Swiss-AF study investigators, Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation , Swiss Medical Weekly: Vol. 147 No. 2728 (2017)
• Loris Cavalli, Luzius Angehrn, Christian Schindler, Niccolò Orsini, Christian Grob, Mark Kaufmann, Luzius A. Steiner, Matthias Schwenkglenks, Salome Dell-Kuster, Number of comorbidities and their impact on perioperative outcome and costs – a single centre cohort study , Swiss Medical Weekly: Vol. 152 No. 1112 (2022)
• Yuki Tomonaga, Dominik Menges, Henock G. Yebyo, Thierry Fumeaux, Antje Heise, Conrad Wesch, Matthias Schwenkglenks, Milo A. Puhan, Early mobilisation and rehabilitation in Swiss intensive care units: a cross-sectional survey , Swiss Medical Weekly: Vol. 152 No. 0304 (2022)
• Tämer El Saadany, Judith E. Lupatsch, Michael Mark, Michaela Barbier, Tarun Mehra, Matthias Schwenkglenks, Roger von Moos, A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland , Swiss Medical Weekly: Vol. 155 No. 1 (2025)
• Rahel Schneider, Daphne Reinau, Nadine Schur, Eva Blozik, Mathias Früh, Andri Signorell, Christoph R. Meier, Matthias Schwenkglenks, Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data , Swiss Medical Weekly: Vol. 149 No. 3940 (2019)
• Arjun Bhadhuri, Ralph Insinga, Patrik Guggisberg, Cedric Panje, Matthias Schwenkglenks, Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland , Swiss Medical Weekly: Vol. 149 No. 5152 (2019)
• Taru Singhal, Kaja Widmer, Anton Beloconi, Suzanne Dhaini, Matthias Schwenkglenks, Cordula Blohm, Rolf Weitkunat, Sabina De Geest, Penelope Vounatsou, Mortality atlas of the main causes of death for the elderly population (≥75 years) in Switzerland during 2010–2020 , Swiss Medical Weekly: Vol. 155 No. 5 (2025)
• Zanfina Ademi, Alena M Pfeil, Elizabeth Hancock, David Trueman, Rola Haroun, Céline Deschaseaux, Matthias Schwenkglenks, Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction , Swiss Medical Weekly: Vol. 147 No. 4546 (2017)
• Zanfina Ademi, Yuki Tomonaga, Joris van Stiphout, Dominik Glinz, Viktoria L. Gloy, Heike Raatz, Heiner C. Bucher, Matthias Schwenkglenks, Adaptation of cost-effectiveness analyses to a single country: the case of bariatric surgery for obesity and overweight , Swiss Medical Weekly: Vol. 148 No. 2324 (2018)